Self-assembled multicomponent prodrugs with GSH/ROS site-responsiveness enable spatiotemporally controlled release for treating resistant NSCLC
Fields of Study & Subjects
Nanoplatforms for cancer theranostics
Nanoparticle-Based Drug Delivery
Advanced biosensing and bioanalysis techniques
Publication details
- Journal / source
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Volume
- 391
- Pages
- 114654–114654
- Publication date
- 22 January 2026
- Language
- EN